Literature DB >> 8358909

Extensile triradiate approach for complex acetabular reconstruction in total hip arthroplasty.

J B Stiehl1, M Harlow, D Hackbarth.   

Abstract

The triradiate approach as described by Mears has been used for open reduction of complex dual-column acetabular fractures. Mears extended the anterior limb of this incision to the symphysis pubis by the ilioinguinal approach. From a consecutive series of 43 total hip revisions, this approach was used successfully in seven cases in which extensile exposure was necessary to revise complicated acetabular reconstructions for arthroplasty. The approach was used also to perform complex acetabular reconstruction after en bloc tumor resection. Three patients had severe intrapelvic component protrusio and anterior column deficiency where close proximity of the prosthesis and femoral neurovascular bundle were detected before surgery. Massive allograft and pelvic reconstructions were used to span large anterior column defects and to stabilize pelvic dehiscence. Complications included one hip dislocation and one posterior flap tip necrosis. Follow-up ranged from six to 34 months. No graft failure has been noted.

Entities:  

Mesh:

Year:  1993        PMID: 8358909

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  3 in total

1.  Acetabular wall deficiency in primary and secondary total hip replacement.

Authors:  J Serafin; W Szulc; A Górecki; I Beheih
Journal:  Eur J Orthop Surg Traumatol       Date:  1995-12

2.  Acetabular Prosthetic Protrusio after Bipolar Hemi-Arthroplasty of the Hip: Case Report and Review of the literature.

Authors:  Jason Bt Lim; Chia Liang Ang; Hee Nee Pang
Journal:  J Orthop Case Rep       Date:  2016 Jul-Aug

Review 3.  [Compression of the external iliac artery by Kerboull frame: report of a case].

Authors:  Nabil Elkoumiti; Hicham El Hyaoui; Abdessalam Achkoun; Abdeljabar Messoudi; Mohamed Rahmi; Abdelhak Garch
Journal:  Pan Afr Med J       Date:  2015-11-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.